Quick Answer
VACCINEX, INC. reported Stockholders Equity of -$2.49 million for fiscal year 2024.
VACCINEX, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$2.49M | -7.7% |
| 2023 | -$2.31M | -144.5% |
| 2022 | $5.19M | -29.9% |
| 2021 | $7.41M | +127.9% |
| 2020 | -$26.57M | -1.3% |
| 2019 | -$26.24M | -204.3% |
| 2018 | -$8.62M | +93.1% |
| 2017 | -$125.45M | -17.2% |
| 2016 | -$107.06M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | -$1.32M | +65.9% | +53.9% |
| June 30, 2024 | -$2.86M | -577.1% | -207.9% |
| March 31, 2024 | $2.65M | +10.6% | +214.9% |
| December 31, 2023 | -$2.31M | -144.5% | +40.3% |
| September 30, 2023 | -$3.87M | -161.2% | -814.7% |
| June 30, 2023 | -$423.0K | -103.9% | -117.6% |
| March 31, 2023 | $2.40M | -85.2% | -53.8% |
| December 31, 2022 | $5.19M | -29.9% | -17.8% |
- VACCINEX, INC. showed a decrease of -7.7% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2024 period, VACCINEX, INC.’s stockholders equity has grown by 97.7% (from -$107.06 million to -$2.49 million).
- The most recent figure is from VACCINEX, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: